625 related articles for article (PubMed ID: 30477496)
21. GDF15 promotes osteosarcoma cell migration and invasion by regulating the TGF‑β signaling pathway.
Chen G; Wang M; Liu X
Mol Med Rep; 2019 Nov; 20(5):4262-4270. PubMed ID: 31545486
[TBL] [Abstract][Full Text] [Related]
22. Tumourigenic canine osteosarcoma cell lines associated with frizzled-6 up-regulation and enhanced side population cell frequency.
de Sá Rodrigues LC; Holmes KE; Thompson V; Newton MA; Stein TJ
Vet Comp Oncol; 2017 Mar; 15(1):78-93. PubMed ID: 25689105
[TBL] [Abstract][Full Text] [Related]
23. The biology of YAP/TAZ: hippo signaling and beyond.
Piccolo S; Dupont S; Cordenonsi M
Physiol Rev; 2014 Oct; 94(4):1287-312. PubMed ID: 25287865
[TBL] [Abstract][Full Text] [Related]
24. Vestigial-like family member 3 (VGLL3), a cofactor for TEAD transcription factors, promotes cancer cell proliferation by activating the Hippo pathway.
Hori N; Okada K; Takakura Y; Takano H; Yamaguchi N; Yamaguchi N
J Biol Chem; 2020 Jun; 295(26):8798-8807. PubMed ID: 32385107
[TBL] [Abstract][Full Text] [Related]
25. In Vitro Validation of the Hippo Pathway as a Pharmacological Target for Canine Mammary Gland Tumors.
Guillemette S; Rico C; Godin P; Boerboom D; Paquet M
J Mammary Gland Biol Neoplasia; 2017 Sep; 22(3):203-214. PubMed ID: 28822004
[TBL] [Abstract][Full Text] [Related]
26. The YAP/TAZ Pathway in Osteogenesis and Bone Sarcoma Pathogenesis.
Kovar H; Bierbaumer L; Radic-Sarikas B
Cells; 2020 Apr; 9(4):. PubMed ID: 32326412
[TBL] [Abstract][Full Text] [Related]
27. The Association of Endothelin-1 Signaling with Bone Alkaline Phosphatase Expression and Protumorigenic Activities in Canine Osteosarcoma.
Neumann ZL; Pondenis HC; Masyr A; Byrum ML; Wycislo KL; Fan TM
J Vet Intern Med; 2015; 29(6):1584-94. PubMed ID: 26426813
[TBL] [Abstract][Full Text] [Related]
28. ΔNp63 mediates cellular survival and metastasis in canine osteosarcoma.
Cam M; Gardner HL; Roberts RD; Fenger JM; Guttridge DC; London CA; Cam H
Oncotarget; 2016 Jul; 7(30):48533-48546. PubMed ID: 27391430
[TBL] [Abstract][Full Text] [Related]
29. Comparative analysis of the surface exposed proteome of two canine osteosarcoma cell lines and normal canine osteoblasts.
Milovancev M; Hilgart-Martiszus I; McNamara MJ; Goodall CP; Seguin B; Bracha S; Wickramasekara SI
BMC Vet Res; 2013 Jun; 9():116. PubMed ID: 23758893
[TBL] [Abstract][Full Text] [Related]
30. The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease.
Varelas X
Development; 2014 Apr; 141(8):1614-26. PubMed ID: 24715453
[TBL] [Abstract][Full Text] [Related]
31. ROCK2 deprivation leads to the inhibition of tumor growth and metastatic potential in osteosarcoma cells through the modulation of YAP activity.
Zucchini C; Manara MC; Cristalli C; Carrabotta M; Greco S; Pinca RS; Ferrari C; Landuzzi L; Pasello M; Lollini PL; Gambarotti M; Donati DM; Scotlandi K
J Exp Clin Cancer Res; 2019 Dec; 38(1):503. PubMed ID: 31878963
[TBL] [Abstract][Full Text] [Related]
32. Wnt/β-Catenin and Hippo Pathway Deregulation in Mammary Tumors of Humans, Dogs, and Cats.
Sammarco A; Gomiero C; Sacchetto R; Beffagna G; Michieletto S; Orvieto E; Cavicchioli L; Gelain ME; Ferro S; Patruno M; Zappulli V
Vet Pathol; 2020 Nov; 57(6):774-790. PubMed ID: 32807036
[TBL] [Abstract][Full Text] [Related]
33. Targeting Mechanotransduction in Osteosarcoma: A Comparative Oncology Perspective.
Luu AK; Viloria-Petit AM
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066583
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of canonical Hedgehog signaling pathway inhibition in canine osteosarcoma.
Baldanza VE; Rogic A; Yan W; Levine CB; Levine RA; Miller AD; McCleary-Wheeler AL
PLoS One; 2020; 15(4):e0231762. PubMed ID: 32348319
[TBL] [Abstract][Full Text] [Related]
35. Transcriptional co-activators YAP1-TAZ of Hippo signalling in doxorubicin-induced cardiomyopathy.
Berecz T; Yiu A; Vittay O; Orsolits B; Mioulane M; Dos Remedios CG; Ketteler R; Merkely B; Apáti Á; Harding SE; Hellen N; Foldes G
ESC Heart Fail; 2022 Feb; 9(1):224-235. PubMed ID: 34931757
[TBL] [Abstract][Full Text] [Related]
36. MiR-34a regulates the invasive capacity of canine osteosarcoma cell lines.
Lopez CM; Yu PY; Zhang X; Yilmaz AS; London CA; Fenger JM
PLoS One; 2018; 13(1):e0190086. PubMed ID: 29293555
[TBL] [Abstract][Full Text] [Related]
37. Expression of the hedgehog signalling pathway and the effect of inhibition at the level of smoothened in canine osteosarcoma cell lines.
Nam A; Song WJ; An JH; Rebhun RB; Youn HY; Seo KW
Vet Comp Oncol; 2022 Dec; 20(4):778-787. PubMed ID: 35521940
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic trial of fluvastatin in a cell line xenograft model of canine mammary gland cancer.
Atmane MI; Vigneau AL; Beaudry F; Rico C; Boerboom D; Paquet M
Vet Comp Oncol; 2023 Dec; 21(4):634-645. PubMed ID: 37709554
[TBL] [Abstract][Full Text] [Related]
39. Porphyromonas gingivalis promotes progression of esophageal squamous cell cancer via TGFβ-dependent Smad/YAP/TAZ signaling.
Qi YJ; Jiao YL; Chen P; Kong JY; Gu BL; Liu K; Feng DD; Zhu YF; Ruan HJ; Lan ZJ; Liu QW; Mi YJ; Guo XQ; Wang M; Liang GF; Lamont RJ; Wang H; Zhou FY; Feng XS; Gao SG
PLoS Biol; 2020 Sep; 18(9):e3000825. PubMed ID: 32886690
[TBL] [Abstract][Full Text] [Related]
40. Desmoglein-3 induces YAP phosphorylation and inactivation during collective migration of oral carcinoma cells.
Ahmad US; Parkinson EK; Wan H
Mol Oncol; 2022 Apr; 16(8):1625-1649. PubMed ID: 35000271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]